Harbin Pharmaceutical Group Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 15,400.37 million compared to CNY 13,755.13 million a year ago. Revenue was CNY 15,456.58 million compared to CNY 13,808.76 million a year ago.

Net income was CNY 395.26 million compared to CNY 465.15 million a year ago. Basic earnings per share from continuing operations was CNY 0.16 compared to CNY 0.19 a year ago. Diluted earnings per share from continuing operations was CNY 0.16 compared to CNY 0.18 a year ago.